734 Endo (Mycophenolate Mofetil 250 mg)
Pill with imprint 734 Endo is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Endo Pharmaceuticals Inc..
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 734 Endo
Mycophenolate Mofetil
- Imprint
- 734 Endo
- Strength
- 250 mg
- Color
- Blue & Orange
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC)
- 60951-0734 (Discontinued)
- Inactive Ingredients
-
ammonia,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
potassium hydroxide,
povidone,
propylene glycol,
shellac,
ferric oxide yellow,
FD&C Blue No. 2,
ferric oxide red,
ferrosoferric oxide,
FD&C Red No. 3
Note: Inactive ingredients may vary.
More about mycophenolate mofetil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 52 Reviews
- Drug class: selective immunosuppressants
Patient resources
- Drug Information
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
- Other brands
- CellCept
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.